UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): ~~January~~March 3125, 2008

RENOVIS, INC.

(Exact name of registrant as specified in its charter)

Delaware

000-50564

94-3353740

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

Two Corporate Drive

San Francisco, California 94080

(Address of Principal Executive Offices)

(650) 266-1400

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨x Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 58.0201 ~~Departure~~Other ~~of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Events.

Renovis, Inc. (d“Renovis”) has scheduled a special meeting of stockholders to vote on the proposal to approve and adopt the Agreement and Plan of Merger, dated September 18, 2007, by and among Evotec AG, a stock corporation organized and existing under the laws of the Federal Republic of Germany (“Evotec”), and Renovis, as amended to date (the “Merger Agreement”) and to approve the merger and related transactions on the terms described in the Merger Agreement. The special meeting will be held at Renovis’s headquarters, located at Two Corporate Drive, South San Francisco, California on May 1, 2008, beginning at 8:00 a.m., Pacific time. Renovis’s Board of Directors previously fixed the close of business on March 18, 2008 as the record date for the determination of the stockholders of Renovis entitled to vote at the special meeting, and any adjournments or postponements thereof.

OnAdditional ~~January 31,~~information 2008, the Compensation Committee of the Board of Directors of Renovis, Inc., a Delaware corporation (“Renovis”) approved cash payments in the amount of $10,600, in lieu of the annual award of options to purchase Renovis common stock, to each member of Board of Directors of Renovis who is an independent director (as determined pursuant to Nasdaq Marketplace Rule 4200(a)(15)), in consideration for the members’ service on the Board. The Compensation Committee did not approve cash payments in lieu of annual stock option grants for directors Corey S. Goodman, Ph.D. and John P. Walker, who are not “independent” as determined pursuant to Nasdaq Marketplace Rule 4200(a)(15).

~~(e)~~Evotec has filed a Registration Statement on Form F-4 with the Securities and Exchange Commission in connection with the proposed merger. Evotec and Renovis expect to mail a joint proxy statement/prospectus, which forms part of the Registration Statement on Form F-4, to stockholders of Renovis in connection with the proposed merger starting on March 27, 2008. This document will contain important information about the merger and should be read before any decision is made with respect to the proposed merger. Investors and stockholders will be able to obtain free copies of this document and any other documents filed or furnished by Evotec or Renovis through the website maintained by the Securities and Exchange Commission at www.sec.gov. Free copies of these documents may also be obtained from Evotec, by directing a request to Evotec’s Investor Relations department at Schnackenburgallee 114, 22525 Hamburg, Germany, or from Renovis, by directing a request to Renovis’ Investor Relations department at Two Corporate Drive, South San Francisco, California 94080. In addition to the documents referenced above, Renovis files or furnishes annual, quarterly and current reports, proxy statements and other information with the Securities and Exchange Commission. You may read and copy any reports, statements or other information filed or furnished by Renovis at the SEC’s Public Reference Room at Station Place, 100 F Street, N.E., Washington, D.C. 20549. You can request copies of these documents by writing to the SEC and paying a fee for the copying cost. Please call the SEC at 1-800-SEC-0330 for more information about the operation of the Public Reference Room. Renovis’s SEC filings are also available to the public at the SEC’s web site at www.sec.gov, or at their web site at www.renovis.com.

OnRenovis, ~~January 31~~Evotec and their respective directors, ~~2008~~executive officers, ~~the Compensation~~certain ~~Committee~~members ~~also~~of ~~approved~~management aand ~~bonus~~certain employees may be deemed to ~~Marlene~~be ~~Perry,~~participants ~~Senior~~in ~~Vice~~the ~~President~~solicitation of ~~Human~~proxies ~~Resources~~in ~~and~~connection ~~Facilities~~with the proposed merger transaction. Additional information regarding the persons who may, inunder the ~~amount~~rules of ~~$50~~the SEC,~~000,~~ ~~conditioned~~be ~~upon~~deemed ~~and~~participants ~~payable~~in ~~immediately~~the solicitation ~~prior~~of toproxies ~~the~~in ~~closing~~connection ofwith the proposed merger ~~between~~transaction, ~~Renovis and~~including ~~Evotec~~a ~~AG,~~description anof ~~Aktiengesellschaft~~the ~~organized~~interests in Renovis of its directors and ~~existing~~executive ~~under~~officers, ~~the~~and ~~laws~~a description of ~~the~~their ~~Federal~~direct ~~Republic~~and ofindirect ~~Germany;~~interests ~~provided,~~in ~~that~~the ~~Ms. Perry~~proposed ~~continues~~merger transaction, tois ~~provide~~set ~~service~~forth toin the ~~Company~~Registration ~~through~~Statement filed with the ~~closing~~SEC referenced above.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	RENOVIS, INC.
Date: February 5, 2008	By	/s/ Jeffrey S. Farrow
Date: March 25, 2008	By:	/s/ Jeffrey Farrow
	Name:	Jeffrey S. Farrow
	Title:	Vice President of Finance and Chief Accounting Officer

Filing Compare · RENOVIS INC